Uncategorised - Page 6

Tourette Syndrome Pipeline 2026: Investigational Therapies, Clinical Trial Advances, and Key Regulatory Developments by DelveInsight

According to DelveInsight’s latest evaluation, the global Tourette syndrome treatment pipeline features more than 6 prominent companies actively advancing over 6 investigational therapies. The comprehensive assessment covers ongoing clinical trials, therapeutic candidates, mechanisms of action, administration routes, and notable developmental milestones. The
25 March 2026

Non-Muscle Invasive Bladder Cancer Pipeline Insight 2026

As per DelveInsight’s assessment, globally, the Non-Muscle Invasive Bladder Cancer pipeline constitutes over 20+ key organizations continuously working towards developing more than 22+ therapeutic candidates for Non-Muscle Invasive Bladder Cancer treatment. The comprehensive analysis encompasses Clinical Trials evaluation, Therapeutic assessment, Mechanism of
30 July 2026

Mismatch Repair Deficiency (dMMR) Market Set to Witness Continued Growth Driven by Rising Testing Uptake, Checkpoint Inhibitor Expansion, and a Robust Emerging Pipeline Through 2034

Mismatch Repair Deficiency (dMMR) Market Summary Mismatch Repair Deficiency (dMMR) causes failure in DNA repair, leading to accumulation of mutations, including in oncogenes and tumor suppressor genes, which promotes uncontrolled cell proliferation and tumor development. dMMR/MSI-H therapies are currently approved for unresectable
28 July 2026
1 4 5 6 7 8 34